Sirio to Launch New BloomDaysTM Postbiotic Gummies Powered by Cargill’s EpiCor® Postbiotic at Expo West 2024

Sirio to Launch New BloomDaysTM Postbiotic Gummies Powered by Cargill’s EpiCor® Postbiotic at Expo West 2024

City of Industry, CA, February 14, 2024 – Sirio Pharma Co., Ltd. (Sirio), a leading global manufacturer of nutritional supplements, is launching BloomDaysTM, a first-to-market postbiotic gummy product featuring EpiCor®, Cargill’s postbiotic ingredient.

BloomDaysTM targets immune health and the growing gut health segment by combining Sirio's expertise in developing and manufacturing health and wellness products with the high-quality, science-backed ingredient, EpiCor®. EpiCor® postbiotic is a unique ingredient from whole food yeast fermentate, backed by 8 human and 8 pre-clinical studies that demonstrate its effectiveness in supporting immune health and positively modulating the gut microbiome.

Sirio’s BloomDaysTM postbiotic gummies meet current consumer demands for health- conscious and sustainable choices. With 500 mg of EpiCor® per 2-gummy serving, these plant-based, sugar-free gummies contain only natural flavors and sweeteners. This uniquely curated formulation aligns with Sirio's commitment to developing products that not only taste great, but also cater to the evolving preferences of consumers.

"We are truly excited to collaborate with Cargill – a global leader committed to nourishing the world in a safe, responsible, and sustainable way to introduce an exceptional product that combines our strengths in health and wellness innovation," said Sara Lesina, General Manager Europe and Americas at Sirio. "BloomDaysTM represents a milestone in our commitment to collaborating with reputable ingredients suppliers to launch innovative and unique solutions for our customers, helping them win in the market. BloomDaysTM not only tastes great and provides meaningful health benefits but also offers a unique value proposition.”

The official launch will be held at Expo West 2024, hosted at the Anaheim Convention Center from March 14, 2024, to March 16, 2024. Attendees are invited to explore the innovative product and Taste the DifferenceTM at Booth #3905, where Sirio will showcase the unique features and benefits of this new offering. Sirio also plans to launch the product in Europe in the second half of 2024 at CPHI Milan.

"We are excited to collaborate with Sirio as they make the health benefits of EpiCor® available to more people through the introduction of their new, postbiotic gummy,” said Adam Hertell, Global Commercial Director of Dietary Supplements, EpiCor®. “With excellent stability properties, EpiCor® offers the versatility and simplicity that pairs well with gummy manufacturing, making for a winning combination.”